Domingo et al. reported that ME/CFS patients had lower antioxidant capacity and higher lipoperoxide, fibroblast growth factor 21, and brain natriuretic peptide (NT-proBNP) [28]. Here, FGF21 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.